Nephrotic syndrome disease activity is proportional to its associated hypercoagulopathy.
Nephrotic syndrome disease activity is proportional to its associated hypercoagulopathy.
复制标题
DOI:
10.1016/j.thromres.2021.02.007
复制
发表时间:
2021-05
影响因子:
7.5
通讯作者:
NEPTUNE Investigators
中科院分区:
文献类型:
--
作者:
Waller AP;Troost JP;Parikh SV;Wolfgang KJ;Rovin BH;Nieman MT;Smoyer WE;Kretzler M;Kerlin BA;NEPTUNE Investigators
Nephrotic syndrome (NS) is associated with an acquired hypercoagulopathy that drives its strong predilection for life-threatening thrombosis. We previously demonstrated that hypercoagulopathy is proportional to NS disease severity in animal models. Therefore, hypercoagulopathy and disease severity may inform thrombosis risk and better guide therapeutic decision making. The objective of this study was thus to establish the relationship between disease severity and hypercoagulopathy in human NS. Thrombin generation assays (TGA) were performed on biorepository plasma samples from a prospective longitudinal NS cohort study. TGA was also determined on a separate cohort of incident NS patients. Multivariable regression was used to build NS-hypercoagulopathy relationship models. Endogenous thrombin potential (ETP) was the TGA parameter most strongly correlated with NS severity and was proportional to conventional measures of NS disease activity including proteinuria, hypercholesterolemia, and hypoalbuminemia. The overall disease activity model was well correlated with ETP (R2=0.38). The relationship with disease activity was confirmed in the second cohort. These models further revealed that ETP is related to disease activity in a manner dependent on remission status. Consistent with our previously reported animal model observations, we found that the combination of proteinuria, hypercholesterolemia, and hypoalbuminemia correlated with ETP-defined hypercoagulopathy. Hypercoagulopathy improved significantly with partial or complete NS remission. These data are expected to inform studies designed to stratify thrombotic risk for patients with NS.
登录
查看更多内容
影响因子:
7.5
作者:
Dargaud, Y.;Luddington, R.;Negrier, C.
通讯作者:
Negrier, C.
影响因子:
10.4
作者:
Attard, C.;van der Straaten, T.;Ignjatovic, V.
通讯作者:
Ignjatovic, V.
影响因子:
12.8
作者:
Emani, Sirisha;Zurakowski, David;Emani, Sitaram M.
通讯作者:
Emani, Sitaram M.
影响因子:
4
作者:
Heit, John A.;Spencer, Frederick A.;White, Richard H.
通讯作者:
White, Richard H.
DOI:
10.1016/s0735-1097(97)00129-0
发表时间:
1997-07-01
影响因子:
24
作者:
Aoki, I;Aoki, N;Ishikawa, K
通讯作者:
Ishikawa, K